© PR Newswire
04.12.2025
VEEV
LISTED
NYSE
Veeva to Present at Upcoming Investor Conference
News Preview
PLEASANTON, Calif., Dec. 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference:
Raymond James 2025 TMT and Consumer Conference, New York, NY. Brian Van Wagener, CFO, and Paul Shawah, EVP Strategy, will present on Monday, December 8, 2025, at 11:20 a.m. Eastern Time.The above presentat...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
PHR
LISTED
NYSE
Phreesia’s Megan Turco Named to MM+M 40 Under 40
News Preview
Phreesia today announced that Megan Turco, Director of Client Experience for Phreesia Network Solutions, has been named to MM+M’s 2025 40 Under 40 list.
MM+M’s annual 40 Under 40 list celebrates standout talent across healthcare marketing and communications. This year’s honorees were chosen for their impact in shaping the future of medical market...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
IMNM
LISTED
NASDAQ
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Immunome, Inc. (the “company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on December 1, 2025, the Compensation Committee of the company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
04.12.2025
OABI
LISTED
NASDAQ
OmniAb to Hold OmniUltra Virtual Investor Event on December 15
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced it will hold a virtual investor event to showcase the launch of OmniUltra™ on Monday, December 15, 2025, beginning at 5:00 p.m. Eastern time.
The event is expected to last approximately one hour and will include a review of OmniAb’s newest technology offering, OmniUltra, the industry's only transgenic c...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
04.12.2025
NGNE
LISTED
NASDAQ
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 4,860 shares of t...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
PLTR
LISTED
NASDAQ
Northslope Signs Large-Scale Expansion for Deployment of Palantir AI FDE and Demonstrates Accelerated Growth; Palantir Recognizes Northslope as the First Partner of the Vanguard: Elite
News Preview
Northslope, the first and fastest growing Palantir-native applied AI company, today announced a deepened strategic partnership with Palantir (NASDAQ: PLTR). This partnership also recognizes Northslope as the first member of the Palantir Vanguard: Elite network, reflecting Northslope’s expanding AI outcomes for customers on Palantir platforms.
This...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
TLSI
LISTED
NASDAQ
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025
News Preview
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, announced today that it will host a virtual key opinion leader (KOL) event on Monday, December 15, 2025 at 2:00 PM ET featuring J...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
CRVO
LISTED
NASDAQ
CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies
News Preview
Phase 2b trial showed significant improvements on primary and key secondary outcomes measures, most prominently in patients without AD co-pathology...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
AVAH
LISTED
NASDAQ
Aveanna to Participate at the BofA Securities Home Care Conference
News Preview
ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the BofA Securities Home Care Conference virtually on December 9, 2025. Management will present at 12:30pm EST and will also host 1x1 investor meetings that same day. Interested investors and...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
TRDA
LISTED
NASDAQ
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Entrada Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4)....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
COO
LISTED
NYSE
CooperCompanies Announces New Chair of the Board and Strategic Review
News Preview
SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that its Board of Directors has appointed Colleen Jay to succeed current Chair Robert Weiss, effective January 2, 2026. Mr. Weiss will remain on the Board and stand for reelection for the upcoming year, marking his...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
COO
LISTED
NYSE
CooperCompanies Announces Fourth Quarter and Full Year 2025 Results
News Preview
SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today financial results for its fiscal fourth quarter and full year ended October 31, 2025....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
04.12.2025
TARA
LISTED
NASDAQ
Protara Announces Proposed Public Offering
News Preview
NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that it has commenced an underwritten public offering of $75 million in aggregate of shares of its common stock or, in lieu o...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
PRAX
LISTED
NASDAQ
Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies
News Preview
Successful interim analysis triggered early stop for efficacy...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on December 1, 2025 to 24 new non-executive employees as equity inducemen...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
PRAX
LISTED
NASDAQ
Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
News Preview
Praxis confirms plans to submit the essential tremor NDA for ulixacaltamide in early 2026 Praxis confirms plans to submit the essential tremor NDA for ulixacaltamide in early 2026...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
HALO
LISTED
NASDAQ
Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in Germany
News Preview
SAN DIEGO, Dec. 4, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), announced today that a German court has granted its request for a preliminary injunction ordering Merck to refrain from distributing and offering Keytruda SC in Germany.The Munich Regional Court's 7th Civil Division found that there is imminent infringem...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
ALVO
LISTED
ICE
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Alvotech (NASDAQ: ALVO) resulting from allegations that Alvotech may have issued materially misleading business information to the investing public.
So What: If you purchased Alvotech securities you may be...
Themefolio
Profiler
Peergroup
© EQS Newswire
04.12.2025
1SXP
LISTED
XETR
SCHOTT Pharmas vorläufige Ergebnisse für das Geschäftsjahr 2025; Ausblick für das Geschäftsjahr 2026 und aktualisierte Mittelfristprognose
News Preview
SCHOTT Pharmas vorläufige Ergebnisse für das Geschäftsjahr 2025; Ausblick für das Geschäftsjahr 2026 und aktualisierte Mittelfristprognose
Vorläufige Ergebnisse für das Geschäftsjahr 2025 entsprechen der Prognose:
Umsatz von 986,2 Mio. Euro (währungsbereinigtes Wachstum von 5,8 %)
EBITDA-Marge steigt auf 28,4 % (Vorjahr: 26,9 %) währungsberein......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.12.2025
1SXP
LISTED
XETR
Outlook for fiscal year 2026 and update of mid-term guidance
News Preview
SCHOTT Pharma: Outlook for fiscal year 2026 and update of mid-term guidance
Today, SCHOTT Pharma issues its financial guidance for fiscal year 2026: The company expects revenue growth at constant currencies in the range of 2-5% and an EBITDA margin of around 27%. This projection deviates from current market expectations (source: Vara consensus as o......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.12.2025
1SXP
LISTED
XETR
Ausblick für das Geschäftsjahr 2026 und Aktualisierung der mittelfristigen Prognose
News Preview
SCHOTT Pharma: Ausblick für das Geschäftsjahr 2026 und Aktualisierung der mittelfristigen Prognose
Für das Geschäftsjahr 2026 erwartet SCHOTT Pharma ein währungsbereinigtes Umsatzwachstum im Bereich von 2-5% sowie eine EBITDA-Marge von rund 27%. Diese Prognose weicht von den aktuellen Markterwartungen von 8,2% währungsbereinigtem Wachstum und einer......
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
ATYR
LISTED
NASDAQ
Deadline Soon: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming December 8, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) common stock between November 7, 2024 and September 12, 2025, inclusive (the...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
UHS
LISTED
NYSE
UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Universal Health Services’s Directors and Officers for Breach of Fiduciary Duties – UHS
News Preview
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Universal Health Services, Inc. (NYSE: UHS) breached their fiduciary duties to Universal Health and its shareholders.
CLICK HERE TO LEARN MORE
Scott+Scott is investigating whether members o...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
GERN
LISTED
NASDAQ
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points
News Preview
Issued on behalf of GT Biopharma, Inc.USA News Group News CommentaryVANCOUVER, BC, Dec. 4, 2025 /PRNewswire/ -- Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination in preclinical models by reprogramming how cancer cells die to trigger powerful immune responses[1], while breakthrough natural killer cell research...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
GERN
LISTED
NASDAQ
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points
News Preview
Issued on behalf of GT Biopharma, Inc.USA News Group News CommentaryVANCOUVER, BC, Dec. 4, 2025 /CNW/ -- Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination in preclinical models by reprogramming how cancer cells die to trigger powerful immune responses[1], while breakthrough natural killer cell research is reve...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
MRK
LISTED
NYSE
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)
News Preview
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest cla...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
ABT
LISTED
NYSE
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
News Preview
Aging, nutrition and lifestyle affect muscles, especially after age 40. That's why Matt Ryan, former professional quarterback and MVP, is teaming up with Abbott to drive muscle health awareness with two new Ensure Max Protein shakesEnsure Max Protein 42g: For physically active adults, this new shake delivers 42 grams of complete protein to help bu...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
CHE
LISTED
NYSE
Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference
News Preview
CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET)....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
COLO B
LISTED
CPH
Coloplast A/S - Decisions at the Annual General Meeting 2025
News Preview
Today, 4 December 2025, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted:...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
04.12.2025
PLTR
LISTED
NASDAQ
Cubic and Palantir Forge Alliance to Accelerate Transformation and Deliver Outcomes for the U.S. Army
News Preview
SAN DIEGO, CA AND DENVER, CO / ACCESS Newswire / December 4, 2025 / Cubic Corporation and its DTECH Mission Solutions business unit, a recognized industry leader in providing trusted, scalable, and intuitive edge compute and networking platforms, today announced a strategic relationship with Palantir Technologies Inc. (NASDAQ:PLTR), to drive large-...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
ACHC
LISTED
NASDAQ
Securities Fraud Investigation Into Acadia Healthcare Company, Inc. (ACHC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
KALA
LISTED
NASDAQ
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
News Preview
ARLINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced that it has entered into definitive agreements for the purchase of an aggregate of 10,000,000 shares of its common stock (or pre-funded warrants in lieu thereof), at a purchase price of $1.00 per share (or pre-funded warrant...
Themefolio
Profiler
Peergroup
© Newsfile
04.12.2025
HEM
LISTED
TSX
Hemostemix Welcomes Shaune Harding, OStJ, RN as Director of Patient Care & Clinical Operations
News Preview
Calgary, Alberta--(Newsfile Corp. - December 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), a leader in autologous stem cell therapeutics for ischemic diseases, is pleased to announce the appointment of Shaune Harding, OStJ, RN non-practicing, as Director of Patient Care & Clinical Operations....
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
VNRX
LISTED
XASE
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis
News Preview
HENDERSON, Nev., Dec. 4, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the inclusion of its Nu.Q® NETs H3.1 assay in "DETECSEPS", a real-world evaluation of early detection of sepsis. DETECSEPS Consortium was awarded winner of the "Challenge Prevention" call for pr...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
EW
LISTED
NYSE
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
News Preview
Edwards Lifesciences (NYSE: EW) will outline its patient-focused strategy and share financial guidance during its annual investor conference. Entering 2026 with momentum for sustainable differentiated growth, Edwards is uniquely positioned with leading therapies across its core structural heart innovations for patients with aortic stenosis (AS), m...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
CTXR
LISTED
NASDAQ
Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim
News Preview
Partnership expands access to LYMPHIR for patients with cutaneous T-cell lymphoma across Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia, and the UAELYMPHIR international availability extends to 19 markets outside the U.S.CRANFORD, N.J., Dec. 4, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
GLMD
LISTED
NASDAQ
Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH
News Preview
The new patent granted in South Korea is added to earlier patents already granted by the United States Patent and Trademark Office (USPTO), Europe, Canada and other jurisdictions and will expire in the U.S. in July 2042.Aramchol is a first-in-class, Phase 3 ready, drug candidate, that showed robust fibrosis improvement in advanced clinical studies...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
UCB
LISTED
EURONEXT
UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting
News Preview
Phase 3 CDKL5 deficiency disorder (CDD) results: UCB shares 21 scientific abstracts, including the presentation of positive primary efficacy and safety results from a phase 3 study of FINTEPLA® (fenfluramine)1 in CDD, marking the third developmental and epileptic encephalopathy (DEE) to see positive results following Dravet syndrome (DS) and Lenno...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
CCRN
LISTED
NASDAQ
Cross Country Healthcare Merger Agreement with Aya Healthcare Terminated
News Preview
Cross Country Healthcare, Inc. (the “Company” and “Cross Country Healthcare”) (Nasdaq: CCRN) today announced the termination of its Agreement and Plan of Merger (the “Merger Agreement” and, the transactions contemplated thereby, the “Aya Merger”) with Aya Holdings II Inc., a Delaware corporation (“Parent”), Spark Merger Sub One Inc., a Delaware co...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
DXCM
LISTED
NASDAQ
Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy
News Preview
DexCom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a new personalised learning platform created with healthcare professionals (HCPs) and for healthcare professionals. The platform is now available in Belgium, Germany, the Kingdom of Sa...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
CVS
LISTED
NYSE
Aetna expands initiatives to simplify experiences for health care professionals and patients
News Preview
Bundling medical procedures and pharmaceutical medications into one prior authorizationImplementing end-to-end generative AI capabilities into Aetna Health appHARTFORD, Conn., Dec. 4, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announces key milestones in support of the company's comprehensive strategy announced in June t...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
ATOS
LISTED
NASDAQ
Atossa Therapeutics Details Accelerated FDA Strategy to Advance (Z)-Endoxifen Across Breast Cancer Continuum
News Preview
Company positioned to pursue expedited regulatory pathways in metastatic, neoadjuvant, and risk-reduction settingsSEATTLE, Dec. 4, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company focused on transforming breast cancer treatment and prevention, announced the comple...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
ODYS
LISTED
NASDAQ
ODYSIGHT.AI ANNOUNCES SUCCESSFUL PROOF-OF-CONCEPT IN THE GLOBAL MINE TRUCK SEGMENT CONDUCTED WITH A MAJOR INTERNATIONAL AUTOMOTIVE OEM
News Preview
OMER, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (NASDAQ: ODYS), a leader in AI-powered visual sensing and Predictive Maintenance (PdM) solutions, announces the successful completion of a Proof of Concept (POC) project in the global mine truck segment conducted with a major international automotive OEM....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
BIOA
LISTED
NASDAQ
BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
News Preview
BGE-102 was well-tolerated in SAD and initial MAD cohorts, with a pharmacokinetic profile supporting once-daily oral dosing...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
CLTX
LISTED
NASDAQ
Akari Therapeutics Provides Corporate Update and Highlights its ADC Payload Innovation Expected to Drive Value in New CEO Corner Segment
News Preview
Access the Akari CEO Corner here...
Themefolio
Profiler
Peergroup
© Newsfile
04.12.2025
FEED
LISTED
NASDAQ
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
News Preview
Event to Take Place December 11th at 4:30 P.M. ETWhite Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it will host a fireside chat on Thursday, December 11, 2025, at 4:3...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
ENVB
LISTED
NASDAQ
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”
News Preview
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that the company will present and participate in the Sachs Associates 9th Annual Neuroscience Innovation Forum on January 11, 2026 d...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
TWST
LISTED
NASDAQ
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade Plasmid DNA Preps designed to support the advancement of pharmaceutical and biotech customers’ pre-clinical studies.
“Our new plasmid preps combine the quality and consistency needed for preclinical research with the speed and co...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
ESLA
LISTED
NASDAQ
Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation
News Preview
Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced that an independent Data Safety Monitoring Board (DSMB) has completed its review of safety data from the Phase I do...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
BAX
LISTED
NYSE
Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027
News Preview
Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the early tender results for the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The tender offers are being made pursuant to the terms and conditions set forth in the offer to purchase, dated Nov. 19, 2025, as amende...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
INTS
LISTED
NASDAQ
Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium
News Preview
SHELTON, Conn., Dec. 4, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using its non-covalent, drug-conjugation technology that creates drug products designed to kill tumors and incr...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
DXCM
LISTED
NASDAQ
DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM
News Preview
LOS ANGELES, Dec. 4, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom " or "the Company") (NASDAQ: DXCM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
CURA
LISTED
TSX
Curaleaf Expands Florida Footprint with New Cape Canaveral Dispensary
News Preview
New location along Florida's Space Coast brings store count to 70 statewide and 159 nationwideSTAMFORD, Conn., Dec. 4, 2025 /CNW/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of its latest dispensary in Cape Canaveral...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
CURA
LISTED
TSX
Curaleaf Expands Florida Footprint with New Cape Canaveral Dispensary
News Preview
New location along Florida's Space Coast brings store count to 70 statewide and 159 nationwideSTAMFORD, Conn., Dec. 4, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of its latest dispensary in Cape Ca...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
LABS
LISTED
TSX
MediPharm Labs Completes First Shipment to France
News Preview
MediPharm Labs is pleased to announce the completion of the Company's first shipment to France....
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
IMAB
LISTED
NASDAQ
NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO
News Preview
Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistanceThe Phase 1 ragistomig study achieved its objective, as the new Q6W extended dosing interval produced strong anti-tumor efficacy in PD-L1-non-respo...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
TRVI
LISTED
NASDAQ
Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer
News Preview
Experienced biotech CFO to lead financial strategy and contribute to the Company's next stage of growthNEW HAVEN, Conn., Dec. 4, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
NRSN
LISTED
NASDAQ
NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026
News Preview
CAMBRIDGE, Mass., Dec. 4, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that following a productive discussion with Health Canada ("Agency"), the Company is resuming its regulatory advanc...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
LMMY
LISTED
OTC
Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview
News Preview
OTC:LMMY Dr. Marvin Hausman, an esteemed Immunologist and Board-Certified Urological Surgeon. With more than five decades of experience in drug research....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
